drugset / Trial / NCT03046251
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate if monthly natalizumab, initiated after delivery, is effective in preventing postpartum relapses.
Timeline
- Start
- 2015-08
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | natalizumab | Monoclonal antibody | 300 mg | Intravenous |